Heilmeier, Ursula http://orcid.org/0000-0003-0664-3413
Burghardt, Andrew J.
Tse, Justin J.
Kapoor, Puneet
Stok, Kathryn S.
Manske, Sarah
Voll, Reinhard E.
Schett, Georg
Finzel, Stephanie
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (FOR2886 PANDORA, CRC1181 Checkpoints for Resolution of Inflammation)
European Research Council (ERC Synergy 4D Nanoscope)
European Calcified Tissue Society (ECTS Academy Personal Research Grant)
The Arthritis Society (STAR-18-0189)
Universitätsklinikum Freiburg
Article History
Received: 6 May 2022
Accepted: 25 November 2022
First Online: 4 February 2023
Declarations
:
: AJ. Burghardt has served as a consultant for Ultragenyx Pharmaceutical Inc. and as a consultant to Mereo BioPharma Group PLC and received research support from Ultragenyx.
: Approval No. 4190 granted by the IRB of the University Clinic of Erlangen; Approval REB19-0387 granted by the University of Calgary’s Conjoint Health Research Ethics Board.
: No animals were harmed in this study.
: Available.
: Available and included in general consent that all participants signed prior to participation.